Pfizer Inc. is pursuing a patent infringement action against Apotex, Mylan and Mylan Inc., Actavis Inc. and Actavis Pharma Manufacturing Pvt. Ltd., and Amneal Pharmaceuticals LLC.
In October 2010, the Company…
Pfizer Inc. is pursuing a patent infringement action against Lupin Limited.
In August 2010, Lupin notified the Company that it had filed an abbreviated new drug application with the FDA seeking…
Pfizer Inc. is pursuing an appeal to the Canadian Federal Court in Toronto’s declaration that its amlodipine besylate patent is invalid.
Certain generic manufacturers are seeking to market generic amlodipine products…
Pfizer Inc. said it will file an action in the Canadian Federal Court in Toronto to prevent approval of Genpharm Inc.’s proposed generic product.
In July 2009, Genpharm Inc. served notice…
Pfizer Inc. pursues a patent infringement action against Matrix Laboratories Limited, Mylan Inc., and another subsidiary of Mylan.
In May 2009, Matrix, a subsidiary of Mylan, notified the Company that it…
The patent infringement complaint filed by Pfizer Inc., Pharmacia & Upjohn Company LLC and Pfizer Health AB against Impax Laboratories, Inc. is in discovery.
In March 2008, Pfizer filed the complaint…